Orrick, Herrington & Sutcliffe LLP reposted this
Our Q2 2024 Life Sciences Snapshot Report with PitchBook is live! The report includes key trends in #venture #investment in #lifesciences and #healthtech. Q1 2024 had the slowest deal count since 2017, but larger deals boosted industry value. Thankfully, #valuations are up across all stages in 2024, including late-stage financings (+42.4%) and early-stage financings (+12.5%). Our roundtable featured a conversation with Katrine Bosley (DaCapo Brainscience), Brittany Cassin, MBA (DigiCARE Realized ), Brian Magierski (21 Impact Labs) and Dean Ornish, M.D. (Ornish Lifestyle Medicine) on brain health innovation! Click below to read more. Thora Johnson | Stephen Thau | Neel Lilani #lifesciences #venturecapital #financing https://lnkd.in/ex7ud-rG
Partner @ Orrick | Cross-Border M&A, Private Equity, Venture Capital
2w